COEP
Coeptis Therapeutics Holdings, Inc.
Key Financials
Net Income
$-11917015
↓ 9.6%
Revenue
$1.4M
↑ Infinity%
Operating Income
$-13043498
↓ 29.7%
Gross Profit
$1.2M
↑ Infinity%
Total Assets
$16.2M
↑ 81.3%
Cash & Equivalents
$404345.00
↓ 55.4%
Total Liabilities
$2.1M
↓ 58.6%
Shareholders' Equity
$13.6M
↑ 325.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 424B3 | 4/17/2026 | View on SEC |
| 144 | 4/16/2026 | View on SEC |
| 8-K | 4/8/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 424B3 | 3/23/2026 | View on SEC |
| 424B3 | 3/23/2026 | View on SEC |
| 424B3 | 3/23/2026 | View on SEC |
| 10-K | 3/19/2026 | View on SEC |
| 4 | 2/13/2026 | View on SEC |
| 4 | 2/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | COEP |
| Company Name | Coeptis Therapeutics Holdings, Inc. |
| CIK | 1759186 |
| Sector | Finance Services |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 6199 |
| SIC Description | Finance Services |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 724-934-6467 |